Creative Planning
NKTR icon

Creative Planning’s Nektar Therapeutics NKTR Stock Holding History

Creative Planning’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-619
Closed -$331K – 2067
2019
Q2 		$331K Sell
619
-101
-14% -$50.6K ﹤0.01% 1312
2019
Q1 		$363K Hold
720
– – ﹤0.01% 1222
2018
Q4 		$355K Buy
720
+2
+0.3% +$1.21K ﹤0.01% 1136
2018
Q3 		$656K Buy
718
+126
+21% +$108K ﹤0.01% 942
2018
Q2 		$434K Buy
592
+332
+128% +$383K ﹤0.01% 1149
2018
Q1 		$414K Buy
+260
New +$335K ﹤0.01% 1177
2017
Q3 		– Sell
-14
Closed -$4K – 3072
2017
Q2 		$4K Sell
14
-40
-74% -$11.6K ﹤0.01% 4104
2017
Q1 		$19K Sell
54
-20
-27% -$4.5K ﹤0.01% 3166
2016
Q4 		$14K Sell
74
-6
-8% -$1.22K ﹤0.01% 3320
2016
Q3 		$21K Buy
80
+43
+116% +$11.1K ﹤0.01% 3033
2016
Q2 		$8K Sell
37
-2,673
-99% -$597K ﹤0.01% 3390
2016
Q1 		$559K Buy
2,710
+73
+3% +$14K ﹤0.01% 709
2015
Q4 		$666K Sell
2,637
-286
-10% -$58.8K 0.01% 639
2015
Q3 		$481K Buy
2,923
+20
+0.7% +$3.54K ﹤0.01% 757
2015
Q2 		$545K Buy
2,903
+176
+6% +$30.3K ﹤0.01% 641
2015
Q1 		$450K Sell
2,727
-1,040
-28% -$214K ﹤0.01% 782
2014
Q4 		$876K Sell
3,767
-66
-2% -$14.1K 0.01% 498
2014
Q3 		$694K Buy
3,833
+666
+21% +$127K 0.01% 543
2014
Q2 		$609K Sell
3,167
-16
-0.5% -$2.83K 0.01% 569
2014
Q1 		$579K Buy
3,183
+13
+0.4% +$2.57K 0.01% 561
2013
Q4 		$540K Sell
3,170
-600
-16% -$96.8K 0.01% 499
2013
Q3 		$591K Sell
3,770
-77
-2% -$14.2K 0.01% 399
2013
Q2 		$666K Buy
+3,847
New +$590K 0.02% 329

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning's NKTR Position: Q3 2019 in Review

Creative Planning sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 619 shares — an estimated $331K sold.

Creative Planning first reported a position in NKTR in Q2 2013 and held it in 23 quarters. The position peaked at $876K in Q4 2014. 287 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

  • Creative Planning reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Creative Planning sold 619 Nektar Therapeutics shares in Q3 2019, an estimated $331K.
  • Creative Planning first reported a position in Nektar Therapeutics in Q2 2013 and held it in 23 quarters.
  • Creative Planning's Nektar Therapeutics position peaked at $876K in Q4 2014.
  • 287 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.